Valuing EQ-5D-Y: the current state of play.

BACKGROUND: For nearly a decade, value sets for the EQ-5D-Y were not available, reflecting challenges in valuing child HRQoL. A methodological research programme led to publication of a valuation protocol in 2020, which was rapidly taken up by local study teams. By the end of 2022, between 11 and 17 EQ-5D-Y value sets will be available, more than for any other child HRQoL measure. It is timely to review the experience of those using the protocol to identify early learnings and remaining issues where more research is needed. METHODS: In June 2021, the EuroQol Group organised a three-day workshop, bringing together all those involved in EQ-5D-Y value set studies and related methodological research concerning EQ-5D-Y and valuation. Workshop discussions were captured by note taking and recording all sessions and online chat. A narrative summary of all sessions was produced and synthesised to identify points of agreement and aspects of methods where uncertainty remains. RESULTS: There was broad agreement that DCE is working well as the principal valuation method. However, the most appropriate means of anchoring the latent scale values produced by DCE remains unclear. Some studies have deviated from the protocol by extending the number of states included in TTO tasks, to better support modelling of DCE and TTO. There is ongoing discussion about the relative merits of alternative variants of TTO and other methods for anchoring. Very few studies have consulted with local end-users to gauge the acceptability of methods used to value EQ-5D-Y. CONCLUSIONS: Priority areas for research include testing alternative methods for anchoring DCE data; exploring the preferences of adolescents; and scale differences in values for EQ-5D-Y and adult EQ-5D states, and implications of such differences for the use of EQ-5D-Y values in HTA. Given the normative elements of the protocol, engaging with HTA bodies and other local users should be the first step for all future value set studies. Value sets undertaken to date are for the three-level EQ-5D-Y. However, the issues discussed in this paper are equally relevant to valuation of the five-level version of EQ-5D-Y; indeed, similar challenges are encountered valuing any measure of child HRQoL.

Assessment of dose inhomogeneity at target level by in vivo dosimetry: can the recommended 5% accuracy in the dose delivered to the target volume be fulfilled in daily practice?

The inhomogeneity of the dose delivered to the target volume due to irregular body surface and tissue densities remains in many cases unknown, since the dose distribution is calculated for most radiation treatments in only one transverse section and assuming the patient to be water equivalent. In the present study, the transmission and the target absorbed dose homogeneity is assessed for 11 head-and-neck cancer treatments by in vivo measurements with silicon diodes. Besides the dose to the specification point, the dose delivered to 2-4 off-axis points in the midline sagittal plane is estimated from entrance and exit dose measurements. Simultaneously made portal films allow to identify the anatomical structures passed by the beam before reaching the exit diode. The mean deviation from the expected transmission is -6.8% for bone, +6% for air cavities and -2.5% for soft tissue. At the midplane, the mean deviations from the expected target dose are respectively -3.5%, +2.3% and -1.9%. The deviations from the prescribed dose are larger than 5% in 12 out of the 39 target points. The accuracy requirement in target dose delivery of plus or minus 5%, as proposed by ICRU, cannot be fulfilled in 7 out of the 11 patients and is mostly due to irregular body contour and tissue densities. As only a limited number of points are considered, the inhomogeneity in the dose delivered throughout the whole irradiated volume is underestimated as is illustrated from the exit dose profiles obtained from the portal image.(ABSTRACT TRUNCATED AT 250 WORDS)

Pre-treatment dosimetric verification by means of a liquid-filled electronic portal imaging device during dynamic delivery of intensity modulated treatment fields.

BACKGROUND AND PURPOSE: Although intensity modulated radiation therapy is characterized by three-dimensional dose distributions which are often superior to those obtained with conventional treatment plans, its routine clinical implementation is partially held back by the complexity of the beam verification. This is even more so when a dynamic multileaf collimator (dMLC) is used instead of a segmented beam delivery. We have therefore investigated the possibility of using a commercially available, liquid-filled electronic portal imaging device (EPID) for the pre-treatment quality assurance of dynamically delivered dose distributions. METHODS AND MATERIALS: A special acquisition mode was developed to optimize the image acquisition speed for dosimetry with the liquid-filled EPID. We investigated the accuracy of this mode for 6 and 18 MV photon beams through comparison with film and ion chamber measurements. The impact of leaf speed and pulse rate fluctuations was quantified by means of dMLC plans especially designed for this purpose. Other factors influencing the accuracy of the dosimetry (e.g. the need for build-up, remanence of the ion concentration in the liquid and bulging of the liquid at non-zero gantry angles) were studied as well. We finally compared dosimetric EPID images with the corresponding image prediction delivered without a patient in the beam. RESULTS: The dosimetric accuracy of the measured dose distribution is approximately 2% with respect to film and ion chamber measurements. The accuracy declines when leaf speed is increased beyond 2 cm/s, but is fairly insensitive to accelerator pulse rate fluctuations. The memory effect is found to be of no clinical relevance. When comparing the acquired and expected distributions, an overall agreement of 3% can be obtained, except at areas of steep dose gradients where slight positional shifts are translated into large errors. CONCLUSIONS: Accurate dosimetric images of intensity modulated beam profiles delivered with a dMLC can be obtained with a commercially available, liquid-filled EPID. The developed acquisition mode is especially suited for fast and accurate pre-treatment verification of the intensity modulated fields.

In vivo dosimetry for tangential breast irradiation: role of the equipment in the accuracy of dose delivery.

Entrance dose measurements (920) have been performed on both tangential treatment fields for 105 breast cancer patients. About half of them (52) were treated on a modern unit (Mevatron, Siemens), supplied with an automatic verification system, the other half (53) were treated on an old therapy unit (cobalt-60). A team of three radiographers worked on the modern unit, while on the old unit only one radiographer was responsible for the treatment set-up. A small systematic error (+ 1.4%) has been detected on the old unit: a small discrepancy existed in the region of the maximum dose between the measured and the published percentage depth-dose values (Br. J. Radiol., Suppl. 17), the latter being used for dose calculation. A striking difference has been observed for the rate of large deviations (deviations of 5% and more from the mean dose): 2.3% (10/430) for the modern unit versus 15% (75/490) for the old one. This shows clearly that the precision in dose delivery is strongly dependent on the characteristics and staffing of the therapy unit, the modern unit being supplied with a check-and-confirm system and with the beam accessory devices in a fixed position in the beam and a team of radiographers being responsible for the set-up.

Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours.

The enormous developments in radiation technology open new horizons for improvements in local tumour control. However, the evolution from conventional external beam radiotherapy planning to conformal therapy might be hampered by the potential risk of over-reliance on the physician's capability of estimating the tumour extent from imaging modalities. The variability between 12 volunteering physicians in the delineation of tumour and target volume on the lateral orthogonal localisation radiograph from CT was assessed for 5 brain tumours. The estimated tumour and target sizes varied, respectively with a factor of 1.3-2.6 and with a factor of 1.3-2.1. The anatomical location of the volumes showed maximum variations from 11 to 27 mm in the cranio-caudal direction and from 14 to 21 mm in the fronto-occipital direction. For the 5 test cases, the tumour area on which all radiation oncologists agreed, represented only 25-73% of the corresponding mean tumour area. Although the introduction of computed tomography in radiation treatment planning was proved to be a major step forwards for treatment planning in many tumour sites, the results of the present study on brain tumours demonstrate that the subjective interpretation of the tumour extent based on CT images might be one of the largest factors contributing to the overall uncertainty in radiation treatment planning. Moreover, this study endorses the need for uncertainty analysis of the medical decision-making process. It may be that the process of making uncertainties explicit can contribute to the improvement of our present concept of radiation treatment planning.(ABSTRACT TRUNCATED AT 250 WORDS)

Is it necessary to repeat quality control procedures for head and neck patients?

Using serial verification films for detection of localization errors and in vivo measurements of the delivered dose, a comparison was made of the information obtained from a single check on the first treatment session or from repeated checks in subsequent irradiations, leading to an assessment of the predictive value of a single check. A total number of 215 films and 261 entrance dose measurements have been performed on 34 fields for 10 head and neck patients. The patients are immobilized with individual plastic masks fixed on the couch and treated on a 6 MV linac, supplied with an automatic verification system excluding the couch parameters. The global results show Gaussian frequency distributions with standard deviations of 4 mm for port film measurements and 3.4% for the dose measurements. Large errors (greater than 5 mm displacement and greater than 4% deviation from the expected dose) have been detected in 16% in the cranio-caudal direction and 24% in the antero-posterior direction with port films and in 15% of the in vivo measurements. In order to identify the nature of the errors, which can be random or systematic, the first measurement is taken as the reference value and shows that consecutive measurements on the same field were reproducible with standard deviations of respectively 2.5 mm and 1.8%. This means that a large part of the spread of the global results can be explained by systematic errors in the treatment preparation chain. With the first check, 6 out of 10 systematic localization errors and 7 out of 7 systematic errors leading to erroneous dose delivery have been detected. Therefore, most of the systematic errors, which affect the overall quality of the treatment, can be identified with the first check. The four systematic localization errors, missed with the first film, were of rather limited size: only one of them showed a mean displacement larger than 7 mm. Because the first measurement is an acceptable indication of the overall quality of the treatment delivery, the authors propose a code of practice for checking the treatment quality at the patient level.

Human errors in data transfer during the preparation and delivery of radiation treatment affecting the final result: "garbage in, garbage out".

Due to the large number of steps and the number of persons involved in the preparation of a radiation treatment, the transfer of information from one step to the next is a very critical point. Errors due to inadequate transfer of information will be reflected in every next step and can seriously affect the final result of the treatment. We studied the frequency and the sources of the transfer errors. A total number of 464 new treatments has been checked over a period of 9 months (January to October 1990). Erroneous data transfer has been detected in 139/24,128 (less than 1%) of the transferred parameters; they affected 26% (119/464) of the checked treatments. Twenty-five of these deviations could have led to large geographical miss or important over- or underdosage (much more than 5%) of the organs in the irradiated volume, thus increasing the complications or decreasing the tumour control probability, if not corrected. Such major deviations, only occurring in 0.1% of the transferred parameters, affected 5% (25/464) of the new treatments. The sources of these large deviations were nearly always human mistakes, whereas a considerable number of the smaller deviations were, in fact, consciously taken decisions to deviate from the intended treatment. Nearly half of the major deviations were introduced during input of the data in the check-and-confirm system, demonstrating that a system aimed to prevent accidental errors, can lead to a considerable number of systematic errors if used as an uncontrolled set-up system. The results of this study show that human mistakes can seriously affect the outcome of patient treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

External audits of electron beams using mailed TLD dosimetry: preliminary results.

AIM: A feasibility study has been performed to investigate the possibility of using mailed thermoluminescence dosimetry (TLD) for external audits of clinical electron beams in Europe. METHODS: In the frame of the EC Network Project for Quality Assurance in Radiotherapy, instruction sheets and mailing procedures have been defined for mailed TLD dosimetry using the dedicated holder developed by a panel of experts of the International Atomic Energy Agency (IAEA). Three hundred and thirty electron beam set-ups have been checked in the reference centres and some local centres of the EC Network Project and in addition through the centres participating to the EORTC Radiotherapy Group trial 22922. RESULTS: The mean ratio of measured dose to stated dose is 0.2% and the standard deviation of measured dose to stated dose is 3.2%. In seven beam set-ups, deviations greater than 10% were observed (max. 66%), showing the usefulness of these checks. CONCLUSION: The results of this feasibility study (instruction sheets, mailing procedures, holder) are presently endorsed by the EQUAL-ESTRO structure in order to offer in the future to all ESTRO members the possibility to request external audits of clinical electron beams.

[Polychlorodibenzo-p-dioxins (author's transl)]. / Les polychloro dibenzo-p-dioxines

Polychlorodibenzo-p-dioxins (chlorodioxins) appear most frequently by heating of chlorophenols in alkaline solution specially when producing organic derivatives. Consequently chlorodioxins may contaminate several industrial chemical products largely used, for instance, as pesticides. Occasionally, chlorodioxins are also synthesized from chlorophenols or their derivatives in situ during industrial processes. Chlorodioxins are the cause of chloracne and chick edema which killed thousands of broiler chickens in the U.S.A. Furthermore chlorodioxins seem to be foetotoxic possible even for man. The present paper is the first part of our work. It is a review of the chemical and toxicological properties of chlorodioxins. We hope to publish later a review of analytical methods and the results of our analyses.

[Osteogenic metaplasia or residual embryonic endometrial ossification?]. / Métaplasie ostéoïde ou ossification embryonnaire résiduelle endométriale?

There are only about 90 cases described in the literature of the presence of an intra-uterine osseous structure--so the condition is not a common one. Often the aetiology is unknown. The purpose of this work is to describe the clinical picture and the anatomo-pathological characteristics on one form which leaves practically no doubt as to how the presence of bony structures in the uterus arise. We call this residual endometrial-ossification (O.R.E.) and note osteogenic or osseous metaplasia. We define O.R.E. as the presence of an osseous structure inside the uterus which does not arise from metaplasia of the cells of the endometrium.

[Dental medicine in the service of the mentally handicapped: personal experiences]. / La médecine dentaire auprès des handicapés mentaux: expériences personnelles.

The article is the reflection of twenty years of experience in dental care for the handicapped. The first part of the article gives you general advises called 'golden rules' and a planning method. In the second part you can find advises how to deal with the different disciplines of dental care as prosthesis, extraction, etc. A lot of examples illustrate the theory.

The effect of sustained phonation at high and low pitch on vocal jitter and shimmer.

Looking for possible signs of vocal fatigue, acoustic waveform perturbation was measured in normal female subjects during sustained phonation at various fundamental frequencies (Fo). At none of the pitch levels a rise of the jitter or the shimmer was found after 25 min of vocalization. On the other hand, an effect of Fo was seen from the start: above the habitual speaking Fo of our subjects' voices there was a tendency for the jitter to be higher and for the shimmer to be lower.